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Acute otitis media (AOM) is a common reason for childhood
primary care visits and antibiotic prescription in the United
Kingdom.1 2 Many randomised controlled trials (RCTs) have
shown that symptoms settle within a few days, irrespective of
antibiotic use,3 with one systematic review reporting that ear
pain takes eight days to resolve fully in 90% of children.4
However observational data and an individual patient data
meta-analysis showed that, among children with AOM, those
with ear discharge have a worse prognosis5 and a more
prolonged duration of ear pain or fever than those without ear
discharge.6 Current guidance from the UKNational Institute for
Health and Care Excellence recommends that general
practitioners consider immediately prescribing oral antibiotics
for children presenting with AOM and ear discharge.7
However, oral antibiotics commonly have side effects such as
diarrhoea, vomiting, and rashes3 and increase the risk of
antimicrobial resistance.8 For children with AOM and ear
discharge, topical antibiotics are a possible alternative because
they put less selective resistance pressure on bacteria and
eardrum perforation allows direct entry of the antibiotic into
the middle ear, without exposing children to systemic side
effects.9 However the risk of ototoxicity is debated.10 11
What is the evidence of uncertainty?
To our knowledge, no RCTs or relevant systematic reviews of
the effectiveness of topical antibiotics for children with AOM
and ear discharge have been published.
Oral antibiotics
By contrast, individual patient data meta-analysis evidence
shows that oral antibiotics are more effective than placebo or
no treatment in reducing the duration of ear pain and fever in
children with AOM and ear discharge; three children need to
be treated with oral antibiotics to prevent one child experiencing
ear pain or fever at 3-7 days (12/51 (24%) patients taking oral
antibiotics v 39/65 (60%) patients taking control treatment).6
However, these benefits should be weighed against the possible
harms, including systemic side effects and increased risk of
antimicrobial resistance.3 8 For example, a systematic review
reported that 27% of children taking oral antibiotics experienced
vomiting, diarrhoea, or rash (283/1044), compared with 20%
(208/1063) taking placebo.3
Topical antibiotics
A recent high quality RCT showed that antibiotic-glucocorticoid
ear drops (not containing aminoglycosides) are clinically more
effective and less costly than oral antibiotics in resolving ear
discharge in children with grommets.12 13 Because a grommet
can be considered a surgically induced eardrum perforation,
this indirectly suggests that topical antibiotics may be as
effective as oral antibiotics for children with AOM presenting
with ear discharge caused by spontaneous perforation of the
eardrum.
Various topical antibiotic formulas are available in the UK,
including those containing aminoglycosides, quinolones (such
as ciprofloxacin with or without dexamethasone), and
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What you need to know
• Consider prescribing oral antibiotics immediately for children presenting with acute otitis media and ear discharge caused by spontaneous
perforation of the eardrum
• Topical antibiotics are associated with fewer systemic side effects and a lower risk of antibiotic resistance than oral antibiotics, but
there is no strong direct evidence to support their use in this condition
chloramphenicol. Of these, quinolone containing drops are
considered most appropriate because chloramphenicol has been
known to cause sensitivity reactions in children and because of
concerns about a link between aminoglycosides and ototoxicity.
While animal studies have indicated that aminoglycoside
antibiotics are potentially ototoxic when applied directly into
the middle ear, the quality of the evidence in humans is debated.
The risk of ototoxicity is generally thought to be low when
topical antibiotics are used at the time of an active middle ear
infection,10 and there seems to be no such risk for quinolone
containing drops.9 10 The British National Formulary states that
topical aminoglycosides or polymyxins are contraindicated in
patients with perforated eardrums or patent ventilation tubes
(grommets).14 By contrast, a UK ear, nose, and throat consensus
statement recommends: in “a patient with a discharging ear, in
whom there is a perforation or patent grommet: if a topical
aminoglycoside is used, this should only be in the presence of
obvious infection...[and] for no longer than two weeks.”10
Is ongoing research likely to provide
relevant evidence?
We searched the trial registries “Netherlands Trial Register’
(NTR), ClinicalTrials.gov, ISRCTNRegister, andmetaRegister
of Controlled Trials (mRCT) (on 1 June 2015) for completed
or ongoing studies on this topic but found no relevant studies.
Our group has submitted grant proposals for two (UK and
Netherlands) primary care based, pragmatic, open, two arm,
individually randomised, non-inferiority controlled trials to
compare the clinical and cost effectiveness of topical and oral
antibiotics in children with AOM and ear discharge.
What should we do in the light of the
uncertainty?
There is currently no strong direct evidence to support the use
of topical antibiotics in children with AOM and ear discharge
caused by spontaneous perforation of the eardrum. On the basis
of current evidence, and in line with current guidance,7 we
recommend that doctors consider offering immediate oral
antibiotics for these children. That said, doctors who are worried
about the adverse effects of oral antibiotics could use the indirect
evidence (from children with grommets) to justify the use of
topical (non-aminoglycoside) antibiotics.12 13Although anecdotal,
our experience suggests that for systemically well children with
(otoscopic signs of) ear discharge but no ear pain, a delayed
antibiotic strategy with advice about the natural course of the
discharge (median duration four days)15 may be appropriate.
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Methods
We systematically searched PubMed, Embase, NHS-CRD (including DARE, NHS-EED, and HTA), and the Cochrane Library from their
inception to 1 June 2015 to identify any published studies comparing the effectiveness of topical antibiotics with oral antibiotics, placebo, or
no treatment in children with AOM presenting with ear discharge caused by spontaneous perforation of the eardrum. No relevant published
studies were found.
Recommendations for further research
Population: children aged 6 months to 16 years with ear discharge caused by spontaneous perforation of the eardrum and ear pain as
the presenting symptoms of acute otitis media (AOM)
Interventions and comparisons: topical antibiotics versus oral antibiotics
Primary outcome: ear pain
Secondary outcomes: duration and severity of systemic (fever, distress or crying, disturbed sleep, interference with normal activity,
appetite) and ear (discharge, odour, hearing loss) symptoms; rescue analgesia; adverse events including serious AOM complications
(such as mastoiditis, meningitis); recurrences of AOM; NHS resource use; disease specific quality of life using OMQ-14 (for younger
children, this can be modified to ear problem related quality of life); antimicrobial resistance; parental satisfaction with treatment allocation
and future desire to use ear drops
How patients were involved in the creation of this article
Patient involvement was not sought for this article. However, we sought advice from a patient and public involvement group (including parents
of children with ear infections) to formulate our research proposal. This group liked the idea of topical antibiotics as an alternative to oral
treatment and thought that ear pain was the most important test of treatment effectiveness because of the distress it causes children and
the disruption to family routines (sleep, work, and schooling).
Discussing the uncertainty with patients
Advise parents of children with AOM and ear discharge that guidelines recommend immediately starting oral antibiotics as these have been
shown to reduce the duration of ear pain and fever. However, explain that these benefits need to be balanced against possible harms
including the risk of side effects, such as diarrhoea, vomiting, and rashes, and increased risk of antimicrobial resistance. Topical antibiotics
are associated with fewer side effects and lower risk of antibiotic resistance than oral antibiotics, but there is currently no strong direct
evidence to support their use in this condition.
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